MBX Biosciences (MBX) News Today $12.48 +0.15 (+1.18%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock MBX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period 50,000 Shares in MBX Biosciences, Inc. (NYSE:MBX) Bought by Aaron Wealth Advisors LLCJuly 4 at 5:04 AM | marketbeat.comMBX Biosciences, Inc. (NYSE:MBX) Receives $37.50 Average Target Price from AnalystsJune 27, 2025 | americanbankingnews.comMBX Biosciences Inc Executives - MorningstarJune 25, 2025 | morningstar.comMMBX Biosciences Appoints Andreas Moraitis, M.D., as Senior Vice President of Clinical Development - MorningstarJune 24, 2025 | morningstar.comMMBX Biosciences Inc Chart - MorningstarJune 24, 2025 | morningstar.comMMBX Biosciences, Inc. (NYSE:MBX) Given Average Rating of "Buy" by AnalystsJune 24, 2025 | marketbeat.comMBX Biosciences Appoints Andreas Moraitis, M.D., as Senior Vice President of Clinical DevelopmentJune 23, 2025 | globenewswire.comMBX Biosciences Submits IND for Obesity TreatmentJune 16, 2025 | tipranks.comMBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of ObesityJune 16, 2025 | globenewswire.comMBX Biosciences to Present at the American Diabetes Association 85th Scientific SessionsJune 10, 2025 | globenewswire.commbx biosciences announces board changes and director electionsJune 7, 2025 | uk.investing.comMBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative BuyMay 31, 2025 | seekingalpha.comWellington Management Group LLP Cuts Position in MBX Biosciences, Inc. (NYSE:MBX)May 31, 2025 | marketbeat.comMBX Biosciences, Inc. (NYSE:MBX) Given Consensus Rating of "Buy" by BrokeragesMay 31, 2025 | marketbeat.comMBX Biosciences, Inc. (NYSE:MBX) Shares Sold by Millennium Management LLCMay 29, 2025 | marketbeat.comNorthern Trust Corp Invests $1.67 Million in MBX Biosciences, Inc. (NYSE:MBX)May 28, 2025 | marketbeat.comWoodline Partners LP Buys 89,046 Shares of MBX Biosciences, Inc. (NYSE:MBX)May 25, 2025 | marketbeat.comCitadel Advisors LLC Grows Stock Holdings in MBX Biosciences, Inc. (NYSE:MBX)May 21, 2025 | marketbeat.comMBX Biosciences to Participate in June Investor ConferencesMay 20, 2025 | globenewswire.comParkman Healthcare Partners LLC Purchases New Shares in MBX Biosciences, Inc. (NYSE:MBX)May 16, 2025 | marketbeat.comMBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate HighlightsMay 12, 2025 | globenewswire.comDriehaus Capital Management LLC Acquires 600,438 Shares of MBX Biosciences, Inc. (NYSE:MBX)May 11, 2025 | marketbeat.comFESM's Underlying Holdings Could Mean 34% Gain PotentialMay 10, 2025 | nasdaq.comMBX Biosciences, Inc. (NYSE:MBX) Stake Lessened by Alyeska Investment Group L.P.May 9, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Purchases New Position in MBX Biosciences, Inc. (NYSE:MBX)May 9, 2025 | marketbeat.comMBX Biosciences, Inc. (NYSE:MBX) Receives Consensus Rating of "Buy" from AnalystsMay 6, 2025 | marketbeat.comMBX Biosciences, Inc. (NYSE:MBX) Shares Sold by Price T Rowe Associates Inc. MDMay 4, 2025 | marketbeat.comMBX Biosciences, Inc. (NYSE:MBX) Shares Purchased by Geode Capital Management LLCApril 28, 2025 | marketbeat.comCompanies Like MBX Biosciences (NASDAQ:MBX) Are In A Position To Invest In GrowthApril 23, 2025 | finance.yahoo.comMBX Biosciences to Participate in Citizens and RBC May Investor ConferencesApril 22, 2025 | globenewswire.comAscendis Pharma initiated with an Outperform at RBC CapitalApril 16, 2025 | markets.businessinsider.comFranklin Resources Inc. Cuts Stock Holdings in MBX Biosciences, Inc. (NYSE:MBX)April 12, 2025 | marketbeat.comJMP Securities Initiates Coverage of MBX Biosciences (MBX) with Market Outperform RecommendationApril 11, 2025 | msn.comOra H. Pescovitz Buys 7,693 Shares of MBX Biosciences, Inc. (NYSE:MBX) StockApril 11, 2025 | insidertrades.comMBX Biosciences initiated with an Outperform at Citizens JMPApril 10, 2025 | markets.businessinsider.comMBX Biosciences adds biotech veteran to boardApril 9, 2025 | uk.investing.comMBX Biosciences appoints Steve Hoerter to board of directorsApril 8, 2025 | markets.businessinsider.comMBX Biosciences Appoints Steve Hoerter to BoardApril 7, 2025 | tipranks.comCharles Schwab Investment Management Inc. Invests $1.72 Million in MBX Biosciences, Inc. (NYSE:MBX)March 30, 2025 | marketbeat.comMBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare ConferenceMarch 26, 2025 | globenewswire.comMBX Biosciences reports Q4 EPS (47c), consensus (59c)March 17, 2025 | markets.businessinsider.comMBX Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate HighlightsMarch 17, 2025 | globenewswire.comInsider Buyers At MBX Biosciences Likely Disappointed With 17% SlideMarch 13, 2025 | finance.yahoo.comMBX Biosciences announces additions to its leadership teamMarch 6, 2025 | markets.businessinsider.comMBX Biosciences Announces Additions to Leadership TeamMarch 5, 2025 | globenewswire.comMBX Biosciences, Inc.'s Lock-Up Period Will Expire on March 12th (NYSE:MBX)March 5, 2025 | marketbeat.comMBX Biosciences completes enrollment in Phase 2 Avail trial of MBX 2109March 3, 2025 | markets.businessinsider.comMBX Biosciences Completes Enrollment in Phase 2 Avail™ Trial of MBX 2109 (Canvuparatide) for HypoparathyroidismMarch 3, 2025 | globenewswire.comOrbiMed Advisors makes $2 million investment in MBX BiosciencesFebruary 21, 2025 | investing.comMbx biosciences director Carl Gordon purchases over $2 million in stockFebruary 21, 2025 | investing.com Get MBX Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Email Address MBX Media Mentions By Week MBX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MBX News Sentiment▼0.950.54▲Average Medical News Sentiment MBX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MBX Articles This Week▼12▲MBX Articles Average Week Get MBX Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mesoblast News Today Schrodinger News Today Vera Therapeutics News Today Evotec News Today Biohaven News Today Ocular Therapeutix News Today Janux Therapeutics News Today 89BIO News Today ANI Pharmaceuticals News Today Edgewise Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MBX) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
